These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 12618480)

  • 1. Involvement of CD70 and CD80 intracytoplasmic domains in the co-stimulatory signal required to provide an antitumor immune response.
    Douin-Echinard V; Péron JM; Lauwers-Cancès V; Favre G; Couderc B
    Int Immunol; 2003 Mar; 15(3):359-72. PubMed ID: 12618480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The expression of CD70 and CD80 by gene-modified tumor cells induces an antitumor response depending on the MHC status.
    Douin-Echinard V; Bornes S; Rochaix P; Tilkin AF; Peron JM; Bonnet J; Favre G; Couderc B
    Cancer Gene Ther; 2000 Dec; 7(12):1543-56. PubMed ID: 11228533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD40 and CD70 co-stimulate a potent in vivo antitumor T cell response.
    Nieland JD; Graus YF; Dortmans YE; Kremers BL; Kruisbeek AM
    J Immunother; 1998 May; 21(3):225-36. PubMed ID: 9610915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A T cell lymphoma can provide potent co-stimulatory effects to T cells that are not mediated by B7-1, B7-2, CD40, HSA or CD70.
    Nieland JD; Kruisbeek AM
    Int Immunol; 1995 Nov; 7(11):1827-38. PubMed ID: 8580081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of the CD27-CD70 co-stimulatory pathway in allogeneic T-cell response to follicular lymphoma cells.
    Schmitter D; Bolliger U; Hallek M; Pichert G
    Br J Haematol; 1999 Jul; 106(1):64-70. PubMed ID: 10444164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of T-cell antitumor immunity and protection against tumor growth by secretion of soluble human CD70 molecules.
    Cormary C; Gonzalez R; Faye JC; Favre G; Tilkin-Mariamé AF
    Cancer Gene Ther; 2004 Jul; 11(7):497-507. PubMed ID: 15153937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased expression of CD80, CD86 and CD70 on T cells from HIV-infected individuals upon activation in vitro: regulation by CD4+ T cells.
    Wolthers KC; Otto SA; Lens SM; Kolbach DN; van Lier RA; Miedema F; Meyaard L
    Eur J Immunol; 1996 Aug; 26(8):1700-6. PubMed ID: 8765009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of antitumor immunity by expression of CD70 (CD27 ligand) or CD154 (CD40 ligand) costimulatory molecules in tumor cells.
    Couderc B; Zitvogel L; Douin-Echinard V; Djennane L; Tahara H; Favre G; Lotze MT; Robbins PD
    Cancer Gene Ther; 1998; 5(3):163-75. PubMed ID: 9622100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant adeno-associated virus (rAAV) vector-mediated cotransduction of CD70 and CD80 into human malignant melanoma cells results in an additive T-cell response.
    Braun-Falco M; Hallek M
    Arch Dermatol Res; 2001 Feb; 293(1-2):12-7. PubMed ID: 11289576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD70 encoded by modified vaccinia virus Ankara enhances CD8 T-cell-dependent protective immunity in MHC class II-deficient mice.
    Bathke B; Pätzold J; Kassub R; Giessel R; Lämmermann K; Hinterberger M; Brinkmann K; Chaplin P; Suter M; Hochrein H; Lauterbach H
    Immunology; 2018 Jun; 154(2):285-297. PubMed ID: 29281850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation by IL-2 of CD70 and CD27 expression on CD8+ T cells: importance for the therapeutic effectiveness of cell transfer immunotherapy.
    Huang J; Kerstann KW; Ahmadzadeh M; Li YF; El-Gamil M; Rosenberg SA; Robbins PF
    J Immunol; 2006 Jun; 176(12):7726-35. PubMed ID: 16751420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential requirement for CD70 and CD80/CD86 in dendritic cell-mediated activation of tumor-tolerized CD8 T cells.
    Bak SP; Barnkob MS; Bai A; Higham EM; Wittrup KD; Chen J
    J Immunol; 2012 Aug; 189(4):1708-16. PubMed ID: 22798683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engagement of CD27 with its ligand CD70 provides a second signal for T cell activation.
    Hintzen RQ; Lens SM; Lammers K; Kuiper H; Beckmann MP; van Lier RA
    J Immunol; 1995 Mar; 154(6):2612-23. PubMed ID: 7876536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD80 and CD86 C domains play an important role in receptor binding and co-stimulatory properties.
    Vasu C; Wang A; Gorla SR; Kaithamana S; Prabhakar BS; Holterman MJ
    Int Immunol; 2003 Feb; 15(2):167-75. PubMed ID: 12578846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune stimulatory effects of CD70 override CD70-mediated immune cell apoptosis in rodent glioma models and confer long-lasting antiglioma immunity in vivo.
    Aulwurm S; Wischhusen J; Friese M; Borst J; Weller M
    Int J Cancer; 2006 Apr; 118(7):1728-35. PubMed ID: 16217761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD27-CD27 ligand/CD70 interactions enhance alloantigen-induced proliferation and cytolytic activity in CD8+ T lymphocytes.
    Brown GR; Meek K; Nishioka Y; Thiele DL
    J Immunol; 1995 Apr; 154(8):3686-95. PubMed ID: 7706711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A human Langerhans cell-like cell line, ELD-1, promotes CD8 T cells to produce IFN-gamma through CD70-dependent alternative pathway.
    Iwamoto S; Ishida M; Tamaoki S; Hagiwara T; Sueki H; Miyazaki A
    Cell Immunol; 2004; 232(1-2):49-56. PubMed ID: 15922715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipopolysaccharide stimulation converts vigorously washed dendritic cells (DCs) to nonexhausted DCs expressing CD70 and evoking long-lasting type 1 T cell responses.
    Iwamoto S; Ishida M; Takahashi K; Takeda K; Miyazaki A
    J Leukoc Biol; 2005 Aug; 78(2):383-92. PubMed ID: 15857939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Critical Role of CD40 and CD70 Signaling in Conventional Type 1 Dendritic Cells in Expansion and Antitumor Efficacy of Adoptively Transferred Tumor-Specific T Cells.
    Oba T; Hoki T; Yamauchi T; Keler T; Marsh HC; Cao X; Ito F
    J Immunol; 2020 Oct; 205(7):1867-1877. PubMed ID: 32848036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneous effects of B7-1 and B7-2 in the induction of both protective and therapeutic anti-tumor immunity against different mouse tumors.
    Martin-Fontecha A; Cavallo F; Bellone M; Heltai S; Iezzi G; Tornaghi P; Nabavi N; Forni G; Dellabona P; Casorati G
    Eur J Immunol; 1996 Aug; 26(8):1851-9. PubMed ID: 8765031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.